Mirati Therapeutics reported $-173307000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Alnylam Pharmaceuticals ALNY:US USD -329357000 54.68M
Astellas Pharma 4503:JP JPY 88.8B 57.12B
AstraZeneca AZN:LN USD 3.09B 52M
Bluebird Bio BLUE:US USD -76513000 16.99M
Eisai 4523:JP JPY -1588000000 11.31B
Exelixis EXEL:US USD 92.04M 3.53M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Johnson & Johnson JNJ:US USD 7.42B 655M
Nektar Therapeutics NKTR:US USD -59204000 99.76M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Roche Holding ROG:VX 12.11B 2.43B
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Spectrum Pharmaceuticals SPPI:US USD -21913000 7.12M
Takeda 4502:JP JPY 64.55B 90.92B
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
YTE INCY:US USD 178.22M 131.36M